CMTM1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.677400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.462600E-01
Normal-vs-Stage2
2.128600E-01
Normal-vs-Stage3
6.989200E-01
Normal-vs-Stage4
3.968800E-01
Stage1-vs-Stage2
2.013900E-02
Stage1-vs-Stage3
9.090600E-01
Stage1-vs-Stage4
5.202600E-01
Stage2-vs-Stage3
2.909600E-01
Stage2-vs-Stage4
8.623000E-01
Stage3-vs-Stage4
4.986000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.630400E-01
Normal-vs-AfricanAmerican
1.789970E-01
Normal-vs-Asian
2.148800E-01
Caucasian-vs-AfricanAmerican
7.181600E-01
Caucasian-vs-Asian
1.134620E-01
AfricanAmerican-vs-Asian
6.292600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.923400E-01
Normal-vs-Female
2.348800E-01
Male-vs-Female
4.650600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.995600E-01
Normal-vs-Age(41-60Yrs)
1.609320E-04
Normal-vs-Age(61-80Yrs)
3.328200E-01
Normal-vs-Age(81-100Yrs)
3.387000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.596200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.653200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.404000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.891800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.150000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.217200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.954570E-01
Normal-vs-Daily Drinker
3.595000E-01
Normal-vs-Weekly Drinker
3.002000E-01
Normal-vs-Occasional Drinker
1.270390E-02
Normal-vs-Social Drinker
3.043800E-01
Non Drinker-vs-Daily Drinker
2.873200E-01
Non Drinker-vs-Weekly Drinker
2.727000E-01
Non Drinker-vs-Occasional Drinker
1.489600E-01
Non Drinker-vs-Social Drinker
6.743800E-01
Daily Drinker-vs-Weekly Drinker
8.832000E-01
Daily Drinker-vs-Occasional Drinker
6.508200E-02
Daily Drinker-vs-Social Drinker
3.069000E-01
Weekly Drinker-vs-Occasional Drinker
5.709900E-02
Weekly Drinker-vs-Social Drinker
2.645200E-01
Occasional Drinker-vs-Social Drinker
2.782200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.067400E-01
Normal-vs-Grade 2
1.210570E-01
Normal-vs-Grade 3
1.036030E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.025000E-04
Grade 1-vs-Grade 3
2.18140000000089E-05
Grade 1-vs-Grade 4
3.067400E-01
Grade 2-vs-Grade 3
5.671700E-02
Grade 2-vs-Grade 4
1.210570E-01
Grade 3-vs-Grade 4
1.036030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.566600E-01
Normal-vs-NonDiabetic
2.701800E-01
Diabetic-vs-NonDiabetic
1.795190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.745760E-01
Normal-vs-NoPancreatitis
2.907000E-01
Pancreatitis-vs-NoPancreatitis
8.988200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.327400E-01
Normal-vs-N1
1.995600E-01
N0-vs-N1
1.545560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.718000000001E-05
Normal-vs-TP53-NonMutant
3.978200E-02
TP53-Mutant-vs-TP53-NonMutant
5.753900E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
